Amicus Therapeutics Inc
NASDAQ:FOLD
Income Statement
Earnings Waterfall
Amicus Therapeutics Inc
Revenue
|
399.4m
USD
|
Cost of Revenue
|
-37.3m
USD
|
Gross Profit
|
362m
USD
|
Operating Expenses
|
-438.1m
USD
|
Operating Income
|
-76.1m
USD
|
Other Expenses
|
-75.5m
USD
|
Net Income
|
-151.6m
USD
|
Income Statement
Amicus Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
0
N/A
|
1
+167%
|
1
+63%
|
2
+23%
|
1
-25%
|
1
-33%
|
0
-63%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
5
+138%
|
9
+82%
|
16
+79%
|
25
+54%
|
37
+47%
|
50
+34%
|
64
+28%
|
73
+15%
|
91
+24%
|
109
+19%
|
131
+21%
|
160
+21%
|
182
+14%
|
209
+15%
|
227
+9%
|
246
+8%
|
261
+6%
|
267
+2%
|
282
+6%
|
294
+4%
|
306
+4%
|
318
+4%
|
321
+1%
|
323
+1%
|
329
+2%
|
337
+2%
|
351
+4%
|
372
+6%
|
399
+7%
|
|
Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(4)
|
(6)
|
(8)
|
(10)
|
(13)
|
(14)
|
(16)
|
(18)
|
(19)
|
(22)
|
(25)
|
(26)
|
(29)
|
(31)
|
(31)
|
(33)
|
(36)
|
(35)
|
(36)
|
(35)
|
(37)
|
(39)
|
(38)
|
(39)
|
(35)
|
(37)
|
|
Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
2
N/A
|
4
+128%
|
8
+83%
|
14
+81%
|
21
+54%
|
31
+47%
|
41
+35%
|
54
+29%
|
61
+13%
|
77
+27%
|
93
+21%
|
113
+22%
|
140
+24%
|
160
+14%
|
184
+15%
|
201
+9%
|
217
+8%
|
230
+6%
|
236
+3%
|
249
+6%
|
258
+4%
|
271
+5%
|
282
+4%
|
286
+1%
|
286
+0%
|
291
+2%
|
299
+3%
|
312
+4%
|
337
+8%
|
362
+7%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(63)
|
(61)
|
(60)
|
(62)
|
(70)
|
(78)
|
(89)
|
(110)
|
(130)
|
(149)
|
(172)
|
(181)
|
(186)
|
(198)
|
(216)
|
25
|
(7)
|
(488)
|
(500)
|
(388)
|
(406)
|
(447)
|
(497)
|
(425)
|
(464)
|
(485)
|
(477)
|
(488)
|
(477)
|
(465)
|
(466)
|
(457)
|
(477)
|
(504)
|
(530)
|
(522)
|
(496)
|
(473)
|
(443)
|
(452)
|
(438)
|
|
Selling, General & Administrative |
(19)
|
(19)
|
(19)
|
(20)
|
(21)
|
(22)
|
(26)
|
(36)
|
(47)
|
(57)
|
(68)
|
(70)
|
(71)
|
(75)
|
(75)
|
(79)
|
(89)
|
(97)
|
(107)
|
(117)
|
(127)
|
(144)
|
(158)
|
(165)
|
(170)
|
(166)
|
(158)
|
(156)
|
(156)
|
(163)
|
(171)
|
(179)
|
(193)
|
(204)
|
(215)
|
(216)
|
(213)
|
(229)
|
(241)
|
(259)
|
(275)
|
|
Research & Development |
(42)
|
(40)
|
(39)
|
(41)
|
(48)
|
(54)
|
(61)
|
(70)
|
(77)
|
(84)
|
(85)
|
(97)
|
(105)
|
(112)
|
(126)
|
(134)
|
(149)
|
(159)
|
(162)
|
(260)
|
(271)
|
(295)
|
(331)
|
(252)
|
(286)
|
(311)
|
(310)
|
(321)
|
(308)
|
(283)
|
(277)
|
(266)
|
(272)
|
(289)
|
(305)
|
(298)
|
(277)
|
(237)
|
(194)
|
(181)
|
(152)
|
|
Depreciation & Amortization |
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
(5)
|
(5)
|
(5)
|
(6)
|
(6)
|
(8)
|
(9)
|
(9)
|
(8)
|
(7)
|
(6)
|
(6)
|
(6)
|
(6)
|
(5)
|
(5)
|
(6)
|
(7)
|
(8)
|
|
Other Operating Expenses |
0
|
(1)
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(3)
|
(4)
|
(7)
|
(17)
|
(11)
|
(7)
|
(8)
|
(12)
|
241
|
234
|
(228)
|
(227)
|
(7)
|
(3)
|
(4)
|
(4)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(3)
|
(10)
|
(10)
|
(5)
|
(7)
|
(5)
|
(4)
|
(1)
|
(1)
|
(3)
|
(3)
|
(4)
|
(3)
|
|
Operating Income |
(62)
N/A
|
(61)
+3%
|
(59)
+3%
|
(61)
-3%
|
(69)
-14%
|
(77)
-12%
|
(89)
-15%
|
(110)
-24%
|
(130)
-19%
|
(149)
-14%
|
(172)
-15%
|
(179)
-4%
|
(182)
-2%
|
(191)
-5%
|
(203)
-6%
|
46
N/A
|
23
-49%
|
(446)
N/A
|
(446)
+0%
|
(327)
+27%
|
(329)
-1%
|
(354)
-8%
|
(383)
-8%
|
(285)
+26%
|
(304)
-7%
|
(301)
+1%
|
(276)
+8%
|
(271)
+2%
|
(247)
+9%
|
(229)
+7%
|
(217)
+5%
|
(199)
+8%
|
(206)
-4%
|
(222)
-8%
|
(244)
-10%
|
(235)
+4%
|
(206)
+13%
|
(174)
+15%
|
(132)
+25%
|
(115)
+13%
|
(76)
+34%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
1
|
1
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(2)
|
(3)
|
(4)
|
(7)
|
(9)
|
(12)
|
(13)
|
(8)
|
(13)
|
(12)
|
(15)
|
(21)
|
(13)
|
(13)
|
(9)
|
(7)
|
(8)
|
(13)
|
(19)
|
(25)
|
(30)
|
(32)
|
(32)
|
(32)
|
(32)
|
(33)
|
(34)
|
(36)
|
(39)
|
(41)
|
(43)
|
|
Non-Reccuring Items |
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(13)
|
(13)
|
0
|
(479)
|
(465)
|
0
|
0
|
0
|
0
|
(36)
|
(41)
|
(41)
|
(41)
|
(5)
|
0
|
(7)
|
(7)
|
0
|
0
|
(0)
|
(0)
|
(7)
|
(7)
|
(7)
|
(7)
|
0
|
(1)
|
(1)
|
(15)
|
|
Total Other Income |
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(5)
|
(4)
|
1
|
3
|
6
|
8
|
1
|
(3)
|
(6)
|
(7)
|
(3)
|
(5)
|
(3)
|
(12)
|
(6)
|
1
|
(1)
|
4
|
(1)
|
(4)
|
(3)
|
2
|
9
|
23
|
4
|
(4)
|
(22)
|
(32)
|
(16)
|
|
Pre-Tax Income |
(63)
N/A
|
(62)
+3%
|
(61)
+1%
|
(63)
-4%
|
(70)
-11%
|
(78)
-12%
|
(91)
-16%
|
(112)
-23%
|
(132)
-18%
|
(152)
-15%
|
(176)
-16%
|
(185)
-5%
|
(204)
-10%
|
(215)
-5%
|
(212)
+2%
|
(441)
-108%
|
(449)
-2%
|
(445)
+1%
|
(459)
-3%
|
(342)
+26%
|
(349)
-2%
|
(418)
-20%
|
(440)
-5%
|
(343)
+22%
|
(356)
-4%
|
(324)
+9%
|
(289)
+11%
|
(291)
0%
|
(274)
+6%
|
(250)
+9%
|
(248)
+1%
|
(235)
+5%
|
(242)
-3%
|
(259)
-7%
|
(274)
-6%
|
(252)
+8%
|
(242)
+4%
|
(214)
+12%
|
(193)
+10%
|
(189)
+2%
|
(150)
+20%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
4
|
4
|
4
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
4
|
4
|
3
|
168
|
162
|
164
|
164
|
(1)
|
0
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
(4)
|
(5)
|
(3)
|
(4)
|
(5)
|
(4)
|
(9)
|
(11)
|
(8)
|
(12)
|
6
|
10
|
8
|
15
|
(1)
|
|
Income from Continuing Operations |
(60)
|
(58)
|
(57)
|
(60)
|
(69)
|
(77)
|
(90)
|
(110)
|
(132)
|
(152)
|
(176)
|
(184)
|
(200)
|
(211)
|
(208)
|
(273)
|
(287)
|
(282)
|
(295)
|
(343)
|
(349)
|
(420)
|
(442)
|
(345)
|
(356)
|
(325)
|
(293)
|
(295)
|
(277)
|
(254)
|
(252)
|
(239)
|
(251)
|
(270)
|
(281)
|
(264)
|
(237)
|
(204)
|
(185)
|
(174)
|
(152)
|
|
Net Income (Common) |
(60)
N/A
|
(58)
+3%
|
(57)
+1%
|
(60)
-4%
|
(69)
-15%
|
(77)
-12%
|
(90)
-16%
|
(110)
-23%
|
(132)
-20%
|
(152)
-15%
|
(176)
-16%
|
(184)
-5%
|
(200)
-8%
|
(211)
-6%
|
(208)
+1%
|
(273)
-31%
|
(284)
-4%
|
(279)
+2%
|
(293)
-5%
|
(340)
-16%
|
(349)
-3%
|
(419)
-20%
|
(442)
-5%
|
(345)
+22%
|
(356)
-3%
|
(325)
+9%
|
(293)
+10%
|
(295)
-1%
|
(277)
+6%
|
(254)
+8%
|
(252)
+1%
|
(239)
+5%
|
(251)
-5%
|
(270)
-8%
|
(281)
-4%
|
(264)
+6%
|
(237)
+10%
|
(204)
+14%
|
(185)
+9%
|
(174)
+6%
|
(152)
+13%
|
|
EPS (Diluted) |
-1.06
N/A
|
-0.9
+15%
|
-0.85
+6%
|
-0.75
+12%
|
-0.93
-24%
|
-0.8
+14%
|
-0.89
-11%
|
-0.93
-4%
|
-1.2
-29%
|
-1.21
-1%
|
-1.35
-12%
|
-1.31
+3%
|
-1.49
-14%
|
-1.48
+1%
|
-1.47
+1%
|
-1.7
-16%
|
-1.87
-10%
|
-1.58
+16%
|
-1.55
+2%
|
-1.79
-15%
|
-1.88
-5%
|
-1.96
-4%
|
-1.85
+6%
|
-1.35
+27%
|
-1.48
-10%
|
-1.26
+15%
|
-1.14
+10%
|
-1.15
-1%
|
-1.07
+7%
|
-0.97
+9%
|
-0.96
+1%
|
-0.9
+6%
|
-0.92
-2%
|
-0.93
-1%
|
-0.96
-3%
|
-0.92
+4%
|
-0.82
+11%
|
-0.7
+15%
|
-0.64
+9%
|
-0.59
+8%
|
-0.51
+14%
|